Exosome intravenous therapeutic (EVerZom)

N/A

Report date: 2025/02/28 10:17:51

Base Information

Drug NameExosome intravenous therapeutic (EVerZom)
Drug Alias NameNaïve exosome intravenous (EVerZom)EViv (EVerZom)
ClassificationBiologics > Exosomes
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsAcute Kidney InjuryEnd Stage Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEverzom
China Registration ClassN/A

Develop Information

Active CompaniesEverzomGenfit SA
Inactive CompaniesN/A
Active IndicationsAcute Kidney InjuryEnd Stage Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A